8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
SpringWorks Therapeutics
5 followers
Genesis Therapeutics
1 follower
Vanguard Clinical
1 follower
4D Molecular Therapeutics
3 followers
GenScript
3 followers
Quantum-Si
2 followers
Worldwide Clinical Trials
4 followers
Scholar Rock
1 follower
Caribou Biosciences
1 follower
Valo
1 follower
SCIEX
1 follower
Explore companies